Mirna Sets Terms For $65 Million IPO
Mirna Therapeutics, a clinical-stage biotech developing microRNA replacement therapies for cancer, announced terms for its IPO on Friday.
The Austin, TX-based company plans to raise $65 million by offering 4.7 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Mirna Therapeutics would command a fully diluted market value of $241 million.
Help employers find you! Check out all the jobs and post your resume.
The Austin, TX-based company plans to raise $65 million by offering 4.7 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Mirna Therapeutics would command a fully diluted market value of $241 million.
Help employers find you! Check out all the jobs and post your resume.